We are live on
!
Find out more
RM
RP Management Portfolio holdings
AUM
$139M
1-Year Est. Return
37.98%
This Fund
S&P 500
This Quarter
Est. Return
-13.75%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$242M
AUM Growth
+$9.51M
(+4.1%)
Cap. Flow
+$37M
Cap. Flow
% of AUM
15.27%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
+$37M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $132M | 54.43% |
1,111,111
| – | – |
|
2
BioCryst Pharmaceuticals
BCRX
$2.66B
| $62.5M | 25.84% |
3,846,154
| – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $47.8M | 19.73% |
31,833,334
+22,666,667
| +247% | +$37M |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $18K | 0.01% |
3,700
| – | – |
|
Similar funds
PC
LA
TP
SC
MFG
MADFP
RM
NC